Clinical Trials Directory

Trials / Completed

CompletedNCT03968510

Swalqol in Primary Hyperparathyroidism

The Effect of Parathyroidectomy on Swallowing Related Quality of Life in Primary Hyperparathyroidism

Status
Completed
Phase
Study type
Observational
Enrollment
150 (actual)
Sponsor
Uşak University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Swallow related quality of life before and after parathyroidectomy will be evaluated in patients with primary hyperparathyridism.

Detailed description

Patients who will undergone parathyroidectomy for primary hyperparathyroidism will be included in the study. Swal-Qol and Sf-36 forms will be used for evaluation of quality of life before and 1 month after the surgery. The change in the quality of life and swallowing related quality of life will be evaluated.

Conditions

Interventions

TypeNameDescription
PROCEDUREparathyroidectomyroutine parathyroidectomy will be done for the treatment of adenoma

Timeline

Start date
2018-11-01
Primary completion
2020-07-01
Completion
2020-11-01
First posted
2019-05-30
Last updated
2021-06-04

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT03968510. Inclusion in this directory is not an endorsement.

Swalqol in Primary Hyperparathyroidism (NCT03968510) · Clinical Trials Directory